AU2001291721A1 - Powdered mannitol and mannitol-containing compositions - Google Patents

Powdered mannitol and mannitol-containing compositions

Info

Publication number
AU2001291721A1
AU2001291721A1 AU2001291721A AU9172101A AU2001291721A1 AU 2001291721 A1 AU2001291721 A1 AU 2001291721A1 AU 2001291721 A AU2001291721 A AU 2001291721A AU 9172101 A AU9172101 A AU 9172101A AU 2001291721 A1 AU2001291721 A1 AU 2001291721A1
Authority
AU
Australia
Prior art keywords
mannitol
powdered
containing compositions
compositions
powdered mannitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291721A
Inventor
Ahmed Al-Ghazawi
Hans Dutler
Othmar Kappeli
Thomas Lutz
Karin Maul
Helmut Schoberl
Eugen Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001291721A1 publication Critical patent/AU2001291721A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
AU2001291721A 2000-08-25 2001-08-02 Powdered mannitol and mannitol-containing compositions Abandoned AU2001291721A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00118106.4 2000-08-25
EP00118106 2000-08-25
PCT/EP2001/008933 WO2002015880A2 (en) 2000-08-25 2001-08-02 Powdered mannitol and mannitol-containing compositions

Publications (1)

Publication Number Publication Date
AU2001291721A1 true AU2001291721A1 (en) 2002-03-04

Family

ID=8169616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291721A Abandoned AU2001291721A1 (en) 2000-08-25 2001-08-02 Powdered mannitol and mannitol-containing compositions

Country Status (4)

Country Link
US (1) US20030188679A1 (en)
EP (1) EP1311243A2 (en)
AU (1) AU2001291721A1 (en)
WO (1) WO2002015880A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482429B1 (en) * 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
EP1446104B2 (en) 2001-11-01 2011-08-03 Novartis AG Spray drying methods
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0228689D0 (en) * 2002-12-09 2003-01-15 Elan Drug Delivery Ltd Compositions
BRPI0418589A (en) 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc pharmaceutical compositions and methods for insulin treatment
EP1893180A2 (en) * 2005-06-07 2008-03-05 Pfizer Products Inc. Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
US8782745B2 (en) * 2006-08-25 2014-07-15 Qwest Communications International Inc. Detection of unauthorized wireless access points
CA2687794C (en) * 2007-05-28 2015-01-27 Jin Satomi Spherical particle of crystalline mannitol
EP2405905B1 (en) 2009-03-09 2016-06-29 SPI Pharma, INC. Highly compactable and durable direct compression excipients and excipient systems
CN102811715A (en) * 2009-12-08 2012-12-05 悉尼大学 Inhalable Formulations
WO2016196804A1 (en) * 2015-06-04 2016-12-08 Balchem Corporation Hydration control for choline salts
US10905660B2 (en) * 2016-06-07 2021-02-02 Novabiotics Limited Microparticles
AU2019311268A1 (en) 2018-07-27 2021-02-11 Chiesi Farmaceutici S.P.A. Novel carrier particles for dry powder formulations for inhalation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
JP3492688B2 (en) * 1992-10-09 2004-02-03 鐘淵化学工業株式会社 Method for producing fine granules
RU2047643C1 (en) * 1993-05-21 1995-11-10 Хан Ир Гвон Material for polarizing coating
US6049428A (en) * 1994-11-18 2000-04-11 Optiva, Inc. Dichroic light polarizers
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
DE19615418A1 (en) * 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol composition
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
JP4711520B2 (en) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 Bioactive peptide-containing powder
FR2807034B1 (en) * 2000-03-29 2002-06-14 Roquette Freres MANNITOL POWDER AND PROCESS FOR PRODUCING THE SAME
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof

Also Published As

Publication number Publication date
EP1311243A2 (en) 2003-05-21
WO2002015880A3 (en) 2002-09-26
US20030188679A1 (en) 2003-10-09
WO2002015880A2 (en) 2002-02-28
WO2002015880A8 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
IL156558A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001256347A1 (en) Deodorant and/or antiperspirant compositions
AU2001291721A1 (en) Powdered mannitol and mannitol-containing compositions
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001276461A1 (en) Cleaning compositions and their use
AU2001265305A1 (en) Compositions containing hexitol and an antiproliferative agent
AU2002251801A1 (en) Composition containing hedychium extract and use thereof
AU1152601A (en) Compositions and their use
AU2001267382A1 (en) Antiperspirant and/or deodorant compositions
AU2000263444A1 (en) Perfume composition and cleaning compositions comprising the perfume composition
AU2002252981A1 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
HK1056564A1 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof.
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4543500A (en) Pharmaceutical compositions and uses
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001232080A1 (en) Compound, compositions and use